[Cardiac biomarkers for diagnosis of myocardial infarction]

Ann Fr Anesth Reanim. 2009 Apr;28(4):321-31. doi: 10.1016/j.annfar.2009.01.017. Epub 2009 Mar 21.
[Article in French]

Abstract

Diagnosis of postoperative myocardial infarction is often difficult, based on tools with a low sensitivity (clinical symptoms, EKG), or with a low specifity (old biomarkers, echocardiographic abnormalities) or inadequate for clinical practice (scintigraphy). Since 1995, clinicians may use more cardiospecific markers (troponin) allowing to modify strategy for postoperative myocardial infarction diagnosis. The aim of this review is to resume such an attitude.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Angina, Unstable / blood
  • Angina, Unstable / diagnosis
  • Biomarkers / blood
  • Cardiac Surgical Procedures
  • Creatine Kinase, MB Form / blood*
  • Diagnosis, Differential
  • Humans
  • Immunoenzyme Techniques
  • Muscle, Skeletal / chemistry
  • Myocardial Infarction / blood
  • Myocardial Infarction / diagnosis*
  • Myocardium / chemistry
  • Myoglobin / blood*
  • Organ Specificity
  • Perioperative Care
  • Postoperative Complications / blood
  • Postoperative Complications / diagnosis*
  • Reproducibility of Results
  • Resuscitation
  • Sensitivity and Specificity
  • Surgical Procedures, Operative
  • Troponin / blood*
  • Troponin / genetics
  • Wounds and Injuries / blood

Substances

  • Biomarkers
  • Myoglobin
  • Troponin
  • Creatine Kinase, MB Form